Study Title: A Phase 4 Study to Assess the Clinical Efficacy of H.P. Acthar Gel 80 U/ml to Improve the Signs and Symptoms in Subjects With Dry Eye Disease

Trial Profile

Study Title: A Phase 4 Study to Assess the Clinical Efficacy of H.P. Acthar Gel 80 U/ml to Improve the Signs and Symptoms in Subjects With Dry Eye Disease

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 03 Sep 2018

At a glance

  • Drugs Corticotropin (Primary)
  • Indications Dry eyes
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 23 Aug 2018 Planned End Date changed from 31 Jul 2018 to 31 Jul 2019.
    • 23 Aug 2018 Planned primary completion date changed from 31 May 2018 to 31 May 2019.
    • 23 Aug 2018 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top